| Summary: |
|
Entry granting NuVox leave to intervene in this matter; that the stipulation is approved in its entirety; that the unresolved issues identified in numbered paragraphs 4, 5, and 7 of the stipulation are resolved in accordance with findings 9 through 11; that CBT is directed to submit compliance studies in accordance with finding 12 and that the procedure for review of those resubmitted studies addressed in finding 12 be followed by the parties. |
|